$12.64
-0.14 (-1.10%)
Open$13.06
Previous Close$12.78
Day High$13.32
Day Low$12.49
52W High$18.69
52W Low$6.92
Volume—
Avg Volume876.8K
Market Cap937.15M
P/E Ratio—
EPS$-2.30
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+96.0% upside
Current
$12.64
$12.64
Target
$24.77
$24.77
$14.60
$24.77 avg
$27.54
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 124.04M | 135.75M | 205.11M |
| Net Income | -90,796,469 | -89,435,068 | -12,900,416 |
| Profit Margin | -73.2% | -69.5% | -6.3% |
| EBITDA | -174,003,345 | -180,916,250 | -15,864,221 |
| Free Cash Flow | — | — | -6,278,593 |
| Rev Growth | -8.6% | -8.6% | +24.6% |
| Debt/Equity | 0.19 | 0.19 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |